Skip to Main Content

Paper Details

Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody.
PLoS Pathog
13
2022
1213H7, 1249A8, IgG, MERS-CoV, S1, S2, S2-specific human monoclonal antibodies, SARS, SARS-, SARS-CoV, SARS-CoV-2, Severe, Severe Acute Respiratory Syndrome Coronavirus, Spike S2 domain-specific, beta-coronavirus, hACE2, hamsters, hmAb, hmAb 1249A8, hmAbs, human, humans, lineage B Beta, mice
Author NameAffiliation
Chengjin YeTexas Biomedical Research Institute
Paul A GoepfertUniversity of Alabama at Birmingham
Luis Martinez-SobridoTexas Biomedical Research Institute
  • 1 - 3

Datasets

Release 1.2